Chi‐Chung Li
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 20
- CAR-T cell therapy research 18
- Immunology 16
- Biosimilars and Bioanalytical Methods 12
- Co-authors
- Anuj Chauhan (4 shared papers)John Urquhart (1 shared paper)Sreeneeranj Kasichayanula (1 shared paper)Shen Yin (8 shared papers)Michael C. Wei (7 shared papers)Yash Kapoor (1 shared paper)Iraj Hosseini (3 shared papers)Sarit Assouline (6 shared papers)
- Journals
- Blood (8 papers)Clinical and Translational Science (6 papers)Clinical Pharmacology & Therapeutics (4 papers)Neurology (3 papers)CPT Pharmacometrics & Systems Pharmacology (2 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Chi‐Chung Li
55 papers receiving 1.7k citations
Chi‐Chung Li's Hit Papers
Peers
Comparison fields: 5 of 121
- Pharmaceutical Science 331
- Oncology 620
- Pathology and Forensic Medicine 381
- Radiology, Nuclear Medicine and Imaging 358
- Immunology 302
Countries citing papers authored by Chi‐Chung Li
This map shows the geographic impact of Chi‐Chung Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Chung Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Chung Li more than expected).
Fields of papers citing papers by Chi‐Chung Li
This network shows the impact of papers produced by Chi‐Chung Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Chung Li. The network helps show where Chi‐Chung Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Chi‐Chung Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study Hit paper breakdown → | 2022 | 244 |
| 2 | 2006 | 202 | |
| 3 | 2005 | 133 | |
| 4 | 2016 | 131 | |
| 5 | 2007 | 84 | |
| 6 | 2020 | 82 | |
| 7 | 2009 | 70 | |
| 8 | 2016 | 55 | |
| 9 | 2007 | 54 | |
| 10 | 1968 | 54 | |
| 11 | 2020 | 51 | |
| 12 | 2010 | 46 | |
| 13 | 2018 | 44 | |
| 14 | 2023 | 44 | |
| 15 | 2016 | 41 | |
| 16 | 2020 | 41 | |
| 17 | 2017 | 34 | |
| 18 | 2011 | 30 | |
| 19 | 2011 | 30 | |
| 20 | 2020 | 27 |
About Chi‐Chung Li
Chi‐Chung Li is a scholar working on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Psychiatry and Mental health and Pathology and Forensic Medicine, having authored 56 papers that have together received 1.8k indexed citations. Recurring topics across this work include CAR-T cell therapy research (18 papers), Migraine and Headache Studies (13 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Biosimilars and Bioanalytical Methods (12 papers), Lymphoma Diagnosis and Treatment (7 papers), Ocular Surface and Contact Lens (4 papers), Trigeminal Neuralgia and Treatments (4 papers) and Advanced Drug Delivery Systems (4 papers). The work is most often cited by research in Pharmaceutical Science (331 citations), Oncology (620 citations), Pathology and Forensic Medicine (381 citations), Radiology, Nuclear Medicine and Imaging (358 citations) and Immunology (302 citations). Chi‐Chung Li has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Anuj Chauhan, John Urquhart, Sreeneeranj Kasichayanula, Shen Yin, Michael C. Wei, Yash Kapoor, Iraj Hosseini, Sarit Assouline, Lihua E. Budde and Nancy L. Bartlett. Their work appears in journals such as Blood, Clinical and Translational Science, Clinical Pharmacology & Therapeutics, Neurology and CPT Pharmacometrics & Systems Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.